For: | Perales S, Torres C, Jimenez-Luna C, Prados J, Martinez-Galan J, Sanchez-Manas JM, Caba O. Liquid biopsy approach to pancreatic cancer. World J Gastrointest Oncol 2021; 13(10): 1263-1287 [PMID: 34721766 DOI: 10.4251/wjgo.v13.i10.1263] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1263.htm |
Number | Citing Articles |
1 |
Nathália Faro de Brito, Luis Felipe Ribeiro Pinto, Matias Eliseo Melendez. Biosensors for liquid biopsy of pancreatic cancer. Microchemical Journal 2024; 196: 109679 doi: 10.1016/j.microc.2023.109679
|
2 |
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Puolakkainen, Sakari Knuutila. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. Biomolecules 2022; 12(5): 652 doi: 10.3390/biom12050652
|
3 |
Hiroki Ueda, Hidenori Takahashi, Ryoto Sakaniwa, Tetsuhisa Kitamura, Shogo Kobayashi, Yoshito Tomimaru, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi. Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis. Pancreatology 2024; 24(7): 1097 doi: 10.1016/j.pan.2024.09.009
|
4 |
Hiroki Ueda, Hidenori Takahashi, Shogo Kobayashi, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi. miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer. Annals of Surgical Oncology 2024; doi: 10.1245/s10434-024-16115-w
|
5 |
A. V. Shabunin, V. V. Ptushkin, M. M. Tavobilov, K. S. Titov, Ju. N. Kobzev, A. A. Karpov, E. B. Kudryash. The role of circulating tumor DNA in diagnosis and optimization of treatment of localized and local pancreatic cancer. Russian Journal of Biotherapy 2023; 22(2): 27 doi: 10.17650/1726-9784-2023-22-2-27-33
|
6 |
Wei Jin, Yuting Fu, Sisi Ge, Han Sun, Kai Pang, Xunbin Wei. In vivo fluorescence flow cytometry reveals that the nanoparticle tumor vaccine OVA@HA-PEI effectively clears circulating tumor cells. Journal of Innovative Optical Health Sciences 2024; 17(06) doi: 10.1142/S1793545824500172
|
7 |
Jeremy W. Roy, Gabriel Wajnberg, Alexie Ouellette, Julie Emilie Boucher, Jacynthe Lacroix, Simi Chacko, Anirban Ghosh, Rodney J. Ouellette, Stephen M. Lewis. Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-36370-3
|
8 |
Folnetti A. Alvarez, Hussein Kaddour, Yuan Lyu, Christina Preece, Jules Cohen, Lea Baer, Alison T. Stopeck, Patricia Thompson, Chioma M. Okeoma. Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment. Breast Cancer Research and Treatment 2022; 196(2): 423 doi: 10.1007/s10549-022-06733-x
|
9 |
Nicholas Aderinto, Muili O. Abdulbasit, Deji Olatunji, Mariam Edun. Unveiling the potential of galectin-3 as a diagnostic biomarker for pancreatic cancer: a review. Annals of Medicine & Surgery 2023; 85(11): 5557 doi: 10.1097/MS9.0000000000001363
|
10 |
Mark Jain, David Atayan, Tagir Rakhmatullin, Tatyana Dakhtler, Pavel Popov, Pavel Kim, Mikhail Viborniy, Iuliia Gontareva, Larisa Samokhodskaya, Vyacheslav Egorov. Cell-Free Tumor DNA Detection-Based Liquid Biopsy of Plasma and Bile in Patients with Various Pancreatic Neoplasms. Biomedicines 2024; 12(1): 220 doi: 10.3390/biomedicines12010220
|